Atlas Trials

Hikma Pharmaceuticals LLC

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hikma Pharmaceuticals LLC

RecordFirmDate
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients (NCT06572982)Hikma Pharmaceuticals LLC2025-04-29
Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML) (NCT06326697)Hikma Pharmaceuticals LLC2024-05-02
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia (NCT05282108)Hikma Pharmaceuticals LLC2022-07-20
Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia (NCT05563818)Hikma Pharmaceuticals LLC2021-11-09
Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region (NCT04468165)Hikma Pharmaceuticals LLC2021-02-23
Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (NCT03625388)Hikma Pharmaceuticals LLC2018-11-05
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients (NCT03452501)Hikma Pharmaceuticals LLC2018-08-26
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt (NCT03454503)Hikma Pharmaceuticals LLC2018-05-13
Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. (NCT03460678)Hikma Pharmaceuticals LLC2018-02-28

Track Hikma Pharmaceuticals LLC automatically

Every clearance here is in the API, with alerts when new ones post.